Emily Rapalino

ID: 1b83d0ce-2619-30fb-68c4

/

Unclaimed

/

Organization: Goodwin Procter

Janssen Files Redacted Public Version of Its Opening Brief in Support of Its Motion for Preliminary Injunction Against Amgen in BPCIA Ustekinumab Case

Big Molecule Watch · March 22, 2023

Mylan Files IPR on Regeneron Aflibercept Patent

Big Molecule Watch · November 4, 2022

Switching Study Concludes That Transition From Humira To Samsung Bioepis’s Adalimumab Biosimilar Is Safe and Effective

Big Molecule Watch · March 3, 2022

FDA Completes Safety Review of Lannett’s IND for Insulin Glargine Biosimilar

Big Molecule Watch · January 25, 2022

Deal news: Bio-Thera Solutions and Intract Pharma

Big Molecule Watch · October 12, 2021